Open access
Open access
Powered by Google Translator Translator

Endocrinology (all articles)

Cohort Study: Metformin Safe for Many Patients with Chronic Kidney Disease

7 Jun, 2018 | 02:49h | UTC

Association of Metformin Use With Risk of Lactic Acidosis Across the Range of Kidney Function: A Community-Based Cohort Study – JAMA Internal Medicine (link to abstract – $ for full-text)

Commentaries: Study Supports Metformin Use at eGFRs as Low as 30 – NEJM Physician’s First Watch (free) AND Metformin safe for most diabetics with kidney disease – UPI (free) AND Evidence Growing Metformin Safe in Many With Diabetes and CKD – Medscape (free registration required)

Related Studies: Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease (link to abstract and commentaries) AND Metformin is linked to reduced mortality in type 2 diabetes with comorbid CKD and CHF – ACP Diabetes Monthly (free)

 


Research: New Risk Calculator Estimates Millions are Being Overtreated with Statins

7 Jun, 2018 | 02:42h | UTC

Clinical Implications of Revised Pooled Cohort Equations for Estimating Atherosclerotic Cardiovascular Disease Risk – Annals of Internal Medicine (link to abstract – $ for full-text)

Commentaries: New risk calculator could change the aspirin, statins, and blood pressure medications some people take – STAT (free) AND Statin recommendations may change, especially for African-Americans – CNN (free) AND Millions could have incorrect statin, aspirin and blood pressure prescriptions – Stanford Medicine, via ScienceDaily (free) AND Current models overestimate CVD risk of 11.8M US adults – Cardiovascular Business (free)

 


Position Statement: Guidance for People with Types 1 and 2 Diabetes Who Fast During Ramadan

1 Jun, 2018 | 04:36h | UTC

Diabetes Canada Position Statement for People with Types 1 and 2 Diabetes Who Fast During Ramadan – Canadian Journal of Diabetes (free)

 


Perspective: For Patients with Type 2 Diabetes, What’s the Best Target Hemoglobin A1C?

1 Jun, 2018 | 04:36h | UTC

For Patients With Type 2 Diabetes, What’s the Best Target Hemoglobin A1C? – JAMA (free for a limited period)

Related: A1C Targets Should Be Personalized to Maximize Benefits While Limiting Risks – Diabetes Care (free) AND Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians (free)

 


Guideline: Type 2 Diabetes Mellitus in Older People

1 Jun, 2018 | 03:48h | UTC

Type 2 diabetes mellitus in older people: a brief statement of key principles of modern day management including the assessment of frailty. A national collaborative stakeholder initiative – Diabetic Medicine (free)

Commentary: New guidance on treating diabetes in elderly and frail adults – University of Exeter, via EurekAlert (free)

 


Cohort Study: Association Between Food Insecurity and Incident Type 2 Diabetes

29 May, 2018 | 18:14h | UTC

The association between food insecurity and incident type 2 diabetes in Canada: A population-based cohort study – PLOS One (free)

Commentary: Food insecurity linked to type 2 diabetes risk – Reuters (free)

“Canadians who cannot afford to eat regularly or to eat a healthy diet have more than double the average risk of developing type 2 diabetes” (from Reuters)

 


Editorial: A1C Targets Should Be Personalized to Maximize Benefits While Limiting Risks

28 May, 2018 | 12:54h | UTC

A1C Targets Should Be Personalized to Maximize Benefits While Limiting Risks – Diabetes Care (free) (via @Abraham_RMI)

Related guideline: Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians (free)

“Clinicians should aim to achieve an HbA1c level between 7% and 8% in most patients with type 2 diabetes” (from ACP Guideline, prompting the Editorial)

 


Cohort Study: Weight Gain with Antidepressant Utilization

28 May, 2018 | 12:38h | UTC

Antidepressant utilisation and incidence of weight gain during 10 years’ follow-up: population based cohort study – The BMJ (free)

Editorial: Antidepressant induced weight gain (free)

Commentaries: Antidepressant therapy and risk of weight gain – The BMJ Opinion (free) AND Taking antidepressants could be linked to weight gain, according to a new study — and some drugs heighten the risk more than others – Business Insider (free) AND Antidepressants linked to risk of weight gain, study shows – OnMedica (free) AND Antidepressant use linked with weight gain – NHS Choices (free)

 


Review: Pitfalls on the Replacement Therapy for Hypothyroidism

24 May, 2018 | 23:13h | UTC

Pitfalls on the replacement therapy for primary and central hypothyroidism in adults – European Journal of Endocrinology (free)

 


Meta-Analysis: Longitudinal Association Between Diabetes and Anxiety

24 May, 2018 | 22:57h | UTC

Investigating the longitudinal association between diabetes and anxiety: a systematic review and meta‐analysis – Diabetic Medicine (free) (via @kamleshkhunti)

 


Randomized Trial: Effectiveness of Text Message Based, Diabetes Self-management Support

24 May, 2018 | 22:19h | UTC

Effectiveness of text message based, diabetes self management support programme (SMS4BG): two arm, parallel randomised controlled trial – The BMJ (free)

Commentaries: The potential of mobile health—reaching those in need – The BMJ Opinion (free)

 


Cohort Study: Egg Consumption and Cardiovascular Disease

23 May, 2018 | 12:32h | UTC

Associations of egg consumption with cardiovascular disease in a cohort study of 0.5 million Chinese adults – Heart (free)

Commentaries: BMJ’s scrambled message on eggs and heart disease: a recipe for rotten news coverage – Health News Review (free) AND Expert reaction to eggs and CVD – Science Media Centre (free) AND No, Eating Eggs Will NOT Protect You From Cardiovascular Death – The Methods Man (free)

 


Guideline Summary: CVD and Risk Management Standards in Diabetes

21 May, 2018 | 13:20h | UTC

Summary with Key Points: CVD and Risk Management Standards in Diabetes – American College of Cardiology (free)

Original Synopsis: Cardiovascular Disease and Risk Management: Review of the American Diabetes Association Standards of Medical Care in Diabetes 2018 – Annals of Internal Medicine (free)

 


Review: Pitfalls on the Replacement Therapy for Hypothyroidism

21 May, 2018 | 13:03h | UTC

Pitfalls on the replacement therapy for primary and central hypothyroidism in adults – European Journal of Endocrinology (free)

 


Randomized Trial: Effectiveness of Text Message Based, Diabetes Self-Management Support Program

21 May, 2018 | 12:58h | UTC

Effectiveness of text message based, diabetes self management support programme (SMS4BG): two arm, parallel randomised controlled trial – The BMJ (free)

Commentary: The potential of mobile health—reaching those in need – The BMJ Opinion (free)

 


Consensus: Adverse Effects of Statin Therapy

18 May, 2018 | 02:34h | UTC

Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract – European Heart Journal (free)

Commentary: EAS Consensus Document Examines Safety of Statins Beyond Muscle Symptoms – TCTMD (free)

 


Position Paper: Some Calories More Harmful Than Others

16 May, 2018 | 01:20h | UTC

Pathways and mechanisms linking dietary components to cardiometabolic disease: thinking beyond calories – Obesity Reviews (free)

Commentary: Some calories more harmful than others – University of California, via EurekAlert (free)

 


Retrospective Cohort: Achieved Systolic BP and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

16 May, 2018 | 00:35h | UTC

Effect of Achieved Systolic Blood Pressure on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus: A Population-Based Retrospective Cohort Study – Diabetes Care (link to abstract – $ for full-text)

Commentaries: Diabetics with lower achieved SBP may be at greater risk for cardiovascular disease – Cardiovascular Business (free) AND No reduced CVD risk for SBP <120 mm hg in type 2 diabetes – MedicalXpress (free)

 


Cluster-Randomized, Crossover Study: Continuous Glucose Monitoring for Glycemic Control in ICU Patients

14 May, 2018 | 11:30h | UTC

Near-Continuous Glucose Monitoring Makes Glycemic Control Safer in ICU Patients – Critical Care Medicine (link to abstract – $ for full-text)

Commentary: Hypoglycemia reduced with continuous glucose monitoring in small trial of ICU patients – ACP Diabetes (free)

 


Randomized Controlled Trial: High-Dose vs. Low-Dose Statin in Stable Coronary Artery Disease

10 May, 2018 | 17:55h | UTC

High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial – Circulation (free)

With a median follow-up of 3.9 years, high-dose as compared with low-dose pitavastatin significantly reduced the risk of the primary end point (4.3% vs 5.4%; NNT = 90), a composite of cardiovascular death, nonfatal myocardial infarction, nonfatal ischemic stroke, or unstable angina requiring emergency hospitalization.

 


Observational Study: Management of Type 1 Diabetes With a Very Low–Carbohydrate Diet

10 May, 2018 | 17:39h | UTC

Management of Type 1 Diabetes With a Very Low–Carbohydrate Diet – Pediatrics (free)

Commentaries: How Low Can You Go? Does Lower Carb Translate to Lower Glucose? – Pediatrics (free) AND Very-low-carb diet shows promise in type 1 diabetes – Boston Children’s Hospital, via ScienceDaily (free) AND How a Low-Carb Diet Might Aid People With Type 1 Diabetes – The New York Times (10 articles per month are free) AND Is Exceptional Control of Type 1 Diabetes Possible with a Low-Carbohydrate Diet? – Dr. David Ludwig Blog (free)

*Randomized controlled trials are warranted.

 


Position Statement: Type 2 diabetes and Heart Failure

10 May, 2018 | 17:34h | UTC

Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology – European Journal of Heat Failure (free)

 


Short Review: Managing Dyslipidemia in Primary Prevention

9 May, 2018 | 16:21h | UTC

Managing Dyslipidemia in Primary Prevention – American College of Cardiology (free)

 


Review: Obesity Emergency Management

9 May, 2018 | 16:20h | UTC

EM Cases: Obesity Emergency Management – emDocs (free)

 


Randomized Controlled Trial: Glyburide vs Insulin for the Treatment of Gestational Diabetes

3 May, 2018 | 20:04h | UTC

Effect of Glyburide vs Subcutaneous Insulin on Perinatal Complications Among Women With Gestational Diabetes: A Randomized Clinical Trial – JAMA (free for a limited period)

Commentaries: Glyburide Should Not Be First-Line for Gestational Diabetes – Medscape (free registration required) AND Glyburide Compared With Insulin for First-Line Tx of Gestational Diabetes – MPR (free)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.